| ADTRAN (NASDAQ:ADTN) is now covered by Evercore Inc. They set an "outperform" rating and a $18.00 price target on the stock. This represents a 18.5% upside from the current price of $15.19. |
| AppLovin (NASDAQ:APP) is now covered by Argus. They set a "buy" rating and a $520.00 price target on the stock. This represents a 20.0% upside from the current price of $433.26. |
| JAN (NYSE:JAN) is now covered by Bank of America Corporation. They set a "buy" rating and a $29.00 price target on the stock. This represents a 18.5% upside from the current price of $24.48. |
| JAN (NYSE:JAN) is now covered by JPMorgan Chase & Co.. They set an "overweight" rating and a $26.00 price target on the stock. This represents a 6.2% upside from the current price of $24.48. |
| Lennox International (NYSE:LII) is now covered by BNP Paribas Exane. They set a "neutral" rating and a $535.00 price target on the stock. This represents a 3.2% upside from the current price of $518.46. |
| McCormick & Company, Incorporated (NYSE:MKC) is now covered by BTIG Research. They set a "neutral" rating on the stock. The current price is $53.97. |
| Merlin, Inc. Common Stock (NASDAQ:MRLN) is now covered by Roth Mkm. They set a "buy" rating and a $15.00 price target on the stock. This represents a 25.0% upside from the current price of $12.00. |
| Mondelez International (NASDAQ:MDLZ) is now covered by BTIG Research. They set a "buy" rating and a $70.00 price target on the stock. This represents a 22.0% upside from the current price of $57.38. |
| Netskope (NASDAQ:NTSK) is now covered by Rosenblatt Securities. They set a "buy" rating and a $15.00 price target on the stock. This represents a 54.4% upside from the current price of $9.71. |
| Omada Health (NASDAQ:OMDA) is now covered by Citizens Jmp. They set a "market outperform" rating and a $18.00 price target on the stock. This represents a 39.0% upside from the current price of $12.95. |
| Relay Therapeutics (NASDAQ:RLAY) is now covered by JonesTrading. They set a "hold" rating and a $18.00 price target on the stock. This represents a 18.8% upside from the current price of $15.15. |
| Trane Technologies (NYSE:TT) is now covered by BNP Paribas Exane. They set an "outperform" rating and a $550.00 price target on the stock. This represents a 17.5% upside from the current price of $468.18. |